School of Medicine, Tzu Chi University, Hualien, Taiwan.
Injury. 2012 Mar;43(3):367-73. doi: 10.1016/j.injury.2011.11.013. Epub 2011 Dec 30.
BACKGROUND: Rhabdomyolysis is one of the causes of acute renal failure. Erythropoietin (EPO) has been found to interact with its receptor (EPO-R) expressed in a large variety of non-haematopoietic tissues to induce a range of pleiotropic cytoprotective actions. In this study, we used recombinant human erythropoietin (rhEPO) to study the effects on the glycerol-induced rhabdomyolysis with acute renal failure in rats. METHODS: Twenty-four rats were divided into three groups as glycerol group, glycerol+EPO group and normal saline+EPO group. Rhabdomyolysis was induced by intramuscular injection of 10 mlkg(-1) 50% glycerol in rats. Ten minutes later, the rats received an intravenous injection of rhEPO (300 Ukg(-1)). Biochemical substances, including haemoglobin, blood urea nitrogen (BUN), creatinine (Cre), glutamic oxaloacetic transaminase (GOT), glutamic pyruvic transaminase (GPT) and creatine phosphokinase (CPK), were measured at 0, 1, 3, 6, 9, 12, 18, 24 and 48 h. Rats were sacrificed 48 h later after glycerol administration and the kidneys were removed immediately for pathology and immunohistochemistry (IHC). RESULTS: Intramuscular injection of glycerol significantly increased blood BUN, Cre, GOT, GPT and CPK levels and induced severe histopathologic damage in the kidneys. Nuclear factor-κB (NF-κB) and inducible nitric oxide synthase (iNOS) were increased and E-cadherin was decreased after glycerol administration, as detected by IHC in the kidneys. Post-treatment with rhEPO decreased blood BUN, Cre, GOT, GPT and CPK levels, decreased markers of kidney injury and suppressed the release of NF-κB and iNOS after rhabdomyolysis. CONCLUSION: Treatment with rhEPO suppressed the activities of NF-κB and iNOS, decreased BUN, Cre, GOT, GPT and CPK levels, and decreased the markers of kidney injury after rhabdomyolysis. These actions ameliorated rhabdomyolysis-induced acute renal failure in rats.
背景:横纹肌溶解症是急性肾衰竭的原因之一。促红细胞生成素 (EPO) 已被发现与在多种非造血组织中表达的其受体 (EPO-R) 相互作用,诱导一系列多效性细胞保护作用。在这项研究中,我们使用重组人促红细胞生成素 (rhEPO) 研究其对甘油诱导的伴有急性肾衰竭的大鼠横纹肌溶解症的影响。
方法:24 只大鼠分为甘油组、甘油+EPO 组和生理盐水+EPO 组。通过肌肉注射 10ml/kg(-1)50%甘油诱导大鼠横纹肌溶解症。10 分钟后,大鼠接受 rhEPO(300U/kg(-1))静脉注射。在 0、1、3、6、9、12、18、24 和 48 小时测量血红蛋白、血尿素氮 (BUN)、肌酐 (Cre)、谷草转氨酶 (GOT)、谷丙转氨酶 (GPT) 和肌酸磷酸激酶 (CPK) 等生化物质。甘油给药后 48 小时处死大鼠,立即取出肾脏进行病理和免疫组织化学 (IHC) 检查。
结果:肌肉注射甘油显著增加血 BUN、Cre、GOT、GPT 和 CPK 水平,并导致肾脏严重的组织病理学损伤。甘油给药后,肾脏 IHC 检测到核因子-κB (NF-κB) 和诱导型一氧化氮合酶 (iNOS) 增加,E-钙黏蛋白减少。rhEPO 治疗后,降低血 BUN、Cre、GOT、GPT 和 CPK 水平,降低肾损伤标志物,并抑制横纹肌溶解后的 NF-κB 和 iNOS 释放。
结论:rhEPO 治疗抑制 NF-κB 和 iNOS 的活性,降低 BUN、Cre、GOT、GPT 和 CPK 水平,减少横纹肌溶解后的肾损伤标志物,改善大鼠横纹肌溶解症引起的急性肾衰竭。
Int J Med Sci. 2017-6-23
Biol Res Nurs. 2009-12-23
Resuscitation. 2007-7
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012-9
World J Orthop. 2025-4-18
Naunyn Schmiedebergs Arch Pharmacol. 2025-3-13
Naunyn Schmiedebergs Arch Pharmacol. 2024-10
Int J Med Sci. 2017-6-23